UA115630U - Спосіб магнітно-резонансної нанотераностики злоякісних пухлин - Google Patents
Спосіб магнітно-резонансної нанотераностики злоякісних пухлин Download PDFInfo
- Publication number
- UA115630U UA115630U UAU201610559U UAU201610559U UA115630U UA 115630 U UA115630 U UA 115630U UA U201610559 U UAU201610559 U UA U201610559U UA U201610559 U UAU201610559 U UA U201610559U UA 115630 U UA115630 U UA 115630U
- Authority
- UA
- Ukraine
- Prior art keywords
- magnetic
- magnetic resonance
- nanocomplex
- hyperthermia
- tumor
- Prior art date
Links
- 230000005291 magnetic effect Effects 0.000 title claims abstract description 50
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 11
- 238000000034 method Methods 0.000 title claims abstract description 11
- 230000003211 malignant effect Effects 0.000 title 1
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 claims abstract description 36
- 229960004679 doxorubicin Drugs 0.000 claims abstract description 18
- 206010020843 Hyperthermia Diseases 0.000 claims abstract description 10
- 230000036031 hyperthermia Effects 0.000 claims abstract description 10
- 230000005672 electromagnetic field Effects 0.000 claims abstract description 9
- 201000011510 cancer Diseases 0.000 claims abstract description 8
- 239000002246 antineoplastic agent Substances 0.000 claims abstract description 6
- 229940041181 antineoplastic drug Drugs 0.000 claims abstract description 6
- 229940031182 nanoparticles iron oxide Drugs 0.000 claims abstract description 5
- 238000002595 magnetic resonance imaging Methods 0.000 claims abstract description 4
- 235000013405 beer Nutrition 0.000 claims 1
- 239000002574 poison Substances 0.000 claims 1
- 231100000614 poison Toxicity 0.000 claims 1
- 241001465754 Metazoa Species 0.000 description 11
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 10
- 239000002105 nanoparticle Substances 0.000 description 9
- 230000000259 anti-tumor effect Effects 0.000 description 7
- 238000009189 magnetic resonance therapy Methods 0.000 description 6
- 206010027476 Metastases Diseases 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 230000010355 oscillation Effects 0.000 description 4
- 230000005294 ferromagnetic effect Effects 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 239000002122 magnetic nanoparticle Substances 0.000 description 3
- 230000005298 paramagnetic effect Effects 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 238000002054 transplantation Methods 0.000 description 3
- 210000004881 tumor cell Anatomy 0.000 description 3
- 208000006552 Lewis Lung Carcinoma Diseases 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 230000005670 electromagnetic radiation Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 230000009401 metastasis Effects 0.000 description 2
- 230000036542 oxidative stress Effects 0.000 description 2
- 230000005414 paramagnetic center Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 238000003325 tomography Methods 0.000 description 2
- 230000004614 tumor growth Effects 0.000 description 2
- 201000009030 Carcinoma Diseases 0.000 description 1
- 102000002812 Heat-Shock Proteins Human genes 0.000 description 1
- 108010004889 Heat-Shock Proteins Proteins 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical group [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 102000009618 Transforming Growth Factors Human genes 0.000 description 1
- 108010009583 Transforming Growth Factors Proteins 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229940045799 anthracyclines and related substance Drugs 0.000 description 1
- 238000011319 anticancer therapy Methods 0.000 description 1
- 239000003972 antineoplastic antibiotic Substances 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 238000002648 combination therapy Methods 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 239000000032 diagnostic agent Substances 0.000 description 1
- 229940039227 diagnostic agent Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 244000144993 groups of animals Species 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- 201000005296 lung carcinoma Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000001394 metastastic effect Effects 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000000771 oncological effect Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000007348 radical reaction Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201610559U UA115630U (xx) | 2016-10-19 | 2016-10-19 | Спосіб магнітно-резонансної нанотераностики злоякісних пухлин |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201610559U UA115630U (xx) | 2016-10-19 | 2016-10-19 | Спосіб магнітно-резонансної нанотераностики злоякісних пухлин |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA115630U true UA115630U (xx) | 2017-04-25 |
Family
ID=58634098
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU201610559U UA115630U (xx) | 2016-10-19 | 2016-10-19 | Спосіб магнітно-резонансної нанотераностики злоякісних пухлин |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA115630U (xx) |
-
2016
- 2016-10-19 UA UAU201610559U patent/UA115630U/uk unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lee et al. | Quo vadis oncological hyperthermia (2020)? | |
| US11918652B2 (en) | Nanoparticles sequentially exposed to low intensity acoustic waves for medical or cosmetic applications | |
| AU2018220863B2 (en) | Magnetic field oscillating at several frequencies for improving efficacy and/or reducing toxicity of magnetic hyperthermia | |
| WO2019018207A1 (en) | TARGETED OSMOTIC LYSE OF MALIGNANT CANCER CELLS USING PULSED MAGNETIC FIELD GRADIENTS | |
| Yang et al. | Eddy current thermal effect based on magnesium microrods for combined tumor therapy | |
| Ogiue-Ikeda et al. | A new method to destruct targeted cells using magnetizable beads and pulsed magnetic force | |
| UA115630U (xx) | Спосіб магнітно-резонансної нанотераностики злоякісних пухлин | |
| Tang et al. | Study of the therapeutic effect of 188Re labeled folate targeting albumin nanoparticle coupled with cis-diamminedichloroplatinum cisplatin on human ovarian cancer | |
| Wang et al. | Advance of nano anticancer therapies targeted on tumor-associated macrophages | |
| UA123258C2 (uk) | Спосіб магнітно-резонансної нанотераностики злоякісних пухлин | |
| UA124427U (uk) | Спосіб магнітно-резонансної нанотераностики злоякісних пухлин | |
| Ceresa et al. | Synchrotron-based photon activation therapy effect on cisplatin pre-treated human glioma stem cells | |
| US20240197883A1 (en) | Nanoparticles sequentially exposed to low intensity acoustic waves for medical or cosmetic applications | |
| US20230143346A1 (en) | Magnetic field or radiation oscillating at several frequencies for improving efficacy and/or reducing toxicity of magnetic hyperthermia | |
| RU2527154C1 (ru) | Способ повышения биодоступности цисплатина в саркому -45, индуцированную в эксперименте | |
| UA111670U (uk) | Спосіб магнітної нанотераностики злоякісних пухлин | |
| UA116274C2 (uk) | Спосіб магнітної нанотераностики злоякісних пухлин | |
| UA102952U (uk) | Спосіб магнітної нанотераностики злоякісних пухлин | |
| UA124108C2 (uk) | Спосіб протипухлинної магнітовакцинації тварин-пухлиноносіїв в експерименті | |
| Grant et al. | EPCT-24 THE REMIND TRIAL: MULTI-ANTIGEN TARGETED T CELLS FOR PEDIATRIC CNS TUMORS | |
| KR20230159096A (ko) | 암 치료용 교류 자기장 발생장치 | |
| KR20240024457A (ko) | 면역 치료용 초상자성 산화철 나노입자의 제조방법 | |
| JPWO2004087208A1 (ja) | 熱ショックタンパク質と磁性微粒子からなる悪性腫瘍の温熱治療剤 | |
| Persson | Treating tumoural diseases (cancer) with a | |
| Persson | Corresponding author: Bertil RR Persson PhD, MDh. c. prof. fem. |